Brainstorm Cell Therapeutics

Brainstorm Cell Therapeutics

Biotechnology Research 12 Bazel Street 32 employees
Employees
32
Contacts
4
Emails
4
Phones
1

Brainstorm Cell Therapeutics Overview

Headquarters
12 Bazel Street
Phone Number
Available in AeroLeads
Industry
Biotechnology Research
Employees
32
Founded
2004
Funding
4.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Brainstorm Cell Therapeutics

BrainStorm Cell Therapeutics Inc. (NASDAQ) develops autologous stem cell therapies for neurodegenerative disorders such as ALS, MS, and Parkinson’s disease. These diseases have limited treatment options and represent unmet medical needs. NurOwn® is BrainStorm’s proprietary process for differentiating autologous mesenchymal stem cells (MSC) into neurotrophic factor (NTF)-secreting cells, transplanted at or near the affected tissue site. Our technology converts MSCs into a living drug delivery system for NTFs. We have proof-of-concept in various animal models of neurodegenerative diseases, including Parkinson's, Huntington's, ALS, MS, and peripheral nerve injury. We have completed two single-arm clinical trials in ALS patients in Israel, demonstrating good safety and tolerability profiles and strong efficacy signals. We also finalized a Phase 3 randomized, double-blind, placebo-controlled clinical trial at multiple US sites, supported by a $16 million USD grant from the California Institute for Regenerative Medicine (CIRM) and another grant from the ALS Association. Currently, we are planning a Phase 3b clinical trial of NurOwn® in ALS under a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA). For more information, visit www.brainstorm-cell.com

Brainstorm Cell Therapeutics Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
1
25.0% coverage

Brainstorm Cell Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Haro Hartounian, Ph.d. CEO - Board Director - C-suite
Email Phone
Mary Kay Turner Results-oriented Leader in Life Science
Email
Bob Dagher, Md Executive Vice President & Chief
Email
Merav Bahat Business Development and Project
Email

Employees by Management Level

Individual contributor 6 profiles
Executive 3 profiles
Manager 3 profiles
VP / Head 1 profile
Senior / Lead 1 profile
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 3 3 0
Healthcare 1 1 0

Brainstorm Cell Therapeutics Tech Stack

Data / AI 3 profiles
Engineering 1 profile

Compare Similar Companies to Brainstorm Cell Therapeutics